News | X-Ray | April 13, 2020

Self-powered X-ray Detector Hopes to Revolutionize Imaging

2-D perovskite thin films boost sensitivity 100-fold compared to conventional detectors, require no outside power source, and enable low-dose dental and medical images

X-ray detectors made with 2-dimensional perovskite thin films convert X-ray photons to electrical signals without requiring an outside power source, and are a hundred times more sensitive than conventional detectors. Image courtesy of Los Alamos National Laboratory

X-ray detectors made with 2-dimensional perovskite thin films convert X-ray photons to electrical signals without requiring an outside power source, and are a hundred times more sensitive than conventional detectors. Image courtesy of Los Alamos National Laboratory

April 13, 2020 — A new X-ray detector prototype is on the brink of revolutionizing medical imaging, with dramatic reduction in radiation exposure and the associated health risks, while also boosting resolution in security scanners and research applications, thanks to a collaboration between Los Alamos National Laboratory and Argonne National Laboratory researchers.

"The perovskite material at the heart of our detector prototype can be produced with low-cost fabrication techniques," said Hsinhan (Dave) Tsai, an Oppenheimer Postdoctoral fellow at Los Alamos National Laboratory. "The result is a cost-effective, highly sensitive, and self-powered detector that could radically improve existing X-ray detectors, and potentially lead to a host of unforeseen applications."

The detector replaces silicon-based technology with a structure built around a thin film of the mineral perovskite, resulting in a hundred times more sensitivity than conventional silicon-based detectors. In addition, the new perovskite detector does not require an outside power source to produce electrical signals in response to X-rays.

High sensitivity perovskite detectors could enable dental and medical images that require a tiny fraction of the exposure that accompanies conventional X-ray imaging. Reduced exposure decreases risks for patients and medical staff alike. The fact that perovskite detectors can be made very thin allows them to offer increased resolution for highly detailed images, which will lead to improved medical evaluations and diagnoses. Lower-energy and increased-resolution detectors could also revolutionize security scanners and imaging in X-ray research applications.

Because perovskite is rich in heavy elements, such as lead and iodine, X-rays that easily pass through silicon undetected are more readily absorbed, and detected, in perovskite. As a result, perovskite significantly outperforms silicon, particularly at detecting high-energy X-rays. This is a crucial advantage when it comes to monitoring X-rays at high-energy research facilities, such as synchrotron light sources.

Perovskite films can be deposited on surfaces by spraying solutions that cure and leave thin layers of the material behind As a result, the thin-layer detectors will be much easier and cheaper to produce than silicon-based detectors, which require high-temperature metal deposition under vacuum conditions.

"Potentially, we could use ink-jet types of systems to print large scale detectors," said Tsai. "This would allow us to replace half-million-dollar silicon detector arrays with inexpensive, higher-resolution perovskite alternatives."

In addition to the promise of thin-layer perovskites in X-ray detectors, thicker layers work well provided they include a small voltage source. This suggests that their useful energy range could be extended beyond X-rays to low-energy gamma-rays.

For more information: www.lanl.gov

Related Content

Kaplan-Meier curves for all-cause mortality in patients with versus without myocardial injury (Panel A) and in patients with versus without myocardial injury according to the presence or absence of major echocardiographic abnormalities (Panel B). *Includes wall motion abnormalities, global left ventricular dysfunction, diastolic dysfunction, right ventricular dysfunction and presence of pericardial effusion. Event rates are censored at 20 days from hospital admission. Images courtesy of Mount Sinai Health S

Kaplan-Meier curves for all-cause mortality in patients with versus without myocardial injury (Panel A) and in patients with versus without myocardial injury according to the presence or absence of major echocardiographic abnormalities (Panel B). *Includes wall motion abnormalities, global left ventricular dysfunction, diastolic dysfunction, right ventricular dysfunction and presence of pericardial effusion. Event rates are censored at 20 days from hospital admission. Images courtesy of Mount Sinai Health System

News | Ultrasound Imaging | October 28, 2020
October 28, 2020 — Card...
Ceiling-mounted X-ray system includes MyExam Companion intelligent user interface to guide technologist through exam workflow
News | X-Ray | October 26, 2020
October 26, 2020 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the...
This illustration show the complexity of the data obtained from one single patient with moderate/severe traumatic brain injury. Different imaging approaches and techniques have their own unique sensitivity in assessing different aspects of neuroanatomy and neuropathology. What can be seen on images also changes with time since injury. Data from comprehensive clinical and functional assessments using a range of other tools is also important for evaluating patient outcome. Through data harmonization and large

This illustration show the complexity of the data obtained from one single patient with moderate/severe traumatic brain injury. Different imaging approaches and techniques have their own unique sensitivity in assessing different aspects of neuroanatomy and neuropathology. What can be seen on images also changes with time since injury. Data from comprehensive clinical and functional assessments using a range of other tools is also important for evaluating patient outcome. Through data harmonization and large-scale analyses of data combined across multiple research sites, the ENIGMA Brain Injury will develop and test methods and procedures for making sense of the complexity in this data. Images courtesy of Olsen et al., Brain Imaging and Behavior, 2020

News | Magnetic Resonance Imaging (MRI) | October 23, 2020
October 23, 2020 — Trau...
A, Initial conventional axial CT image shows no noticeable lung damage (within red box) in right upper lobe. B, Electron density spectral CT image obtained at same time as image in A shows lesions (within red box) in right upper lobe. C, Follow-up conventional axial chest CT image obtained 5 days after images in A and B confirm presence of lesions (within red box) in right upper lobe.

A, Initial conventional axial CT image shows no noticeable lung damage (within red box) in right upper lobe. B, Electron density spectral CT image obtained at same time as image in A shows lesions (within red box) in right upper lobe. C, Follow-up conventional axial chest CT image obtained 5 days after images in A and B confirm presence of lesions (within red box) in right upper lobe. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | October 22, 2020
October 22, 2020 — According to an open-...
The fMRI hyperscanning environment.

(A) The fMRI hyperscanning environment. The clinician (1) and patient (2) were positioned in two different 3T MRI scanners. An audio-video link enabled online communication between the two scanners (3), and video images were used to extract frame-by-frame facial expression metrics. During simultaneous acquisition of blood oxygen level–dependent (BOLD)–fMRI data, the clinician used a button box (4) to apply electroacupuncture (EA) treatment (real/sham, double-blind) to the patient (5) to alleviate evoked pressure pain to the leg (6; Hokanson cuff inflation). Pain and affect related to the treatment were rated after each trial. (B) Study overview. After an initial behavioral visit, each individual participated in a Clinical-Interaction (hyperscan preceded by a clinical intake) and No-Interaction condition (hyperscan without a preceding intake), in a counterbalanced order, with two different partners. (C) Experimental protocol. Each hyperscan was composed of 12 repeated trials (four verum EA, four sham EA, and four no treatment) in a pseudo-randomized order. After a resting period (far left), both participants were shown a visual cue to indicate whether the next pain stimulus would be treated (green frame) or not treated (red frame) by the clinician. These cues prompted clinicians prepare to either apply or not apply treatment while evoking corresponding anticipation for the patient. Following the anticipation cue, moderately painful pressure pain was applied to the patient’s left leg, while the clinician applied or did not apply treatment, respectively. After another resting period, participants rated pain (patients), vicarious pain (clinicians), and affect (both) using a visual analog scale (VAS).

News | Clinical Trials | October 22, 2020
October 22, 2020 — The potential impact of the patient-clinician relationship on a patient's response to treatment is
Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA)

Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA) MR image shows lesion is homogeneously hyperintense compared with liver parenchyma. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Magnetic Resonance Imaging (MRI) | October 21, 2020
October 21, 2020 — According to an artic...
According to an inquest, a man with a heart disorder and chest pain died two days after a doctor viewed the wrong scan and sent him home
News | Computed Tomography (CT) | October 21, 2020
October 21, 2020 — The BBC News
Flowchart of patient inclusion and exclusion.

Figure 1. Flowchart of patient inclusion and exclusion.

News | Coronavirus (COVID-19) | October 20, 2020
October 20, 2020 — A new multi-institutional study published in the journal ...
Rensselaer, First-Imaging, and GE Global researchers develop a deep neural network to perform nearly as well as more complex dual-energy CT imaging technology
News | Computed Tomography (CT) | October 20, 2020
October 20, 2020 — Bioimaging technologies are the eyes that allow doctors to see inside the body in order to diagnos